|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/535 | |||
| A61K 31/573 | |||
| A61K 31/704 | |||
| A61K 31/454 | |||
| A61K 31/69 | |||
| A61K 31/436 | |||
| A61P 35/00 |
| (11) | Number of the document | 2405916 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10708866.8 |
| Date of filing the European patent application | 2010-03-11 | |
| (97) | Date of publication of the European application | 2012-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/026903 |
| Date | 2010-03-11 |
| (87) | Number | WO 2010/105008 |
| Date | 2010-09-16 |
| (30) | Number | Date | Country code |
| 159622 P | 2009-03-12 | US |
| (72) |
EBENS, Allen, J., Jr., US
FRIEDMAN, Lori, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES |
| COMBINATIONS OF PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF HEMATOPOIETIC MALIGNANCIES |